학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 51건 | 목록 1~20
Academic Journal
Koo KM; The University of Queensland Centre for Clinical Research (UQCCR), Brisbane, QLD, Australia.; XING Applied Research & Assay Development (XARAD) Division, XING Technologies Pty Ltd, Brisbane, QLD, Australia.; Centre for Personalized Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Brisbane, QLD, Australia.; Phillips G; XING Applied Research & Assay Development (XARAD) Division, XING Technologies Pty Ltd, Brisbane, QLD, Australia.; Srihari S; QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Translational and Human Immunology Laboratory, Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.; Farrell Á; The University of Queensland Centre for Clinical Research (UQCCR), Brisbane, QLD, Australia.; Jaradi B; XING Applied Research & Assay Development (XARAD) Division, XING Technologies Pty Ltd, Brisbane, QLD, Australia.; Fitzpatrick KJ; XING Applied Research & Assay Development (XARAD) Division, XING Technologies Pty Ltd, Brisbane, QLD, Australia.; Yaxley JW; The University of Queensland Centre for Clinical Research (UQCCR), Brisbane, QLD, Australia.; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia.; Samaratunga H; The University of Queensland Centre for Clinical Research (UQCCR), Brisbane, QLD, Australia.; Aquesta Specialized Uropathology, Brisbane, QLD, Australia.; Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Brisbane, QLD, Australia.; Mainwaring PN; XING Applied Research & Assay Development (XARAD) Division, XING Technologies Pty Ltd, Brisbane, QLD, Australia.; Ru KL; Centre for Personalized Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Brisbane, QLD, Australia.; Korbie DJ; Centre for Personalized Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Brisbane, QLD, Australia.; Tomlins SA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA.; Strata Oncology, Ann Arbor, MI, USA.; Roberts MJ; The University of Queensland Centre for Clinical Research (UQCCR), Brisbane, QLD, Australia.; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia.; Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Brisbane, QLD, Australia.; Gardiner RA; The University of Queensland Centre for Clinical Research (UQCCR), Brisbane, QLD, Australia.; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia.; Edith Cowan University, Perth, WA, Australia.; Trau M; Centre for Personalized Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Brisbane, QLD, Australia.; School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD, Australia.
Publisher: WILEY-VCH Country of Publication: Germany NLM ID: 101664569 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2198-3844 (Electronic) Linking ISSN: 21983844 NLM ISO Abbreviation: Adv Sci (Weinh) Subsets: MEDLINE
Academic Journal
Immunotherapy (1750743X); Oct2022, Vol. 14 Issue 14, p1165-1179, 15p
Academic Journal
Cella, D, Escudier, B, Tannir, N M, Powles, T, Donskov, F, Peltola, K, Schmidinger, M, Heng, D Y C, Mainwaring, P N, Hammers, H J, Lee, J L, Roth, B J, Marteau, F, Williams, P, Baer, J, Mangeshkar, M, Scheffold, C, Hutson, T E, Pal, S, Motzer, R J & Choueiri, T K 2018, 'Quality of Life Outcomes for Cabozantinib Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma: METEOR Phase III Randomized Trial', Journal of Clinical Oncology, vol. 36, no. 8, pp. 757-764. https://doi.org/10.1200/JCO.2017.75.2170
Academic Journal
Oudard, S, Fizazi, K, Sengeløv, L, Daugaard, G, Saad, F, Hansen, S, Hjälm-Eriksson, M, Jassem, J, Thiery-Vuillemin, A, Caffo, O, Castellano, D, Mainwaring, P N, Bernard, J, Shen, L, Chadjaa, M & Sartor, O 2017, ' Cabazitaxel Versus Docetaxel As First-Line Therapy for Patients With Metastatic Castration-Resistant Prostate Cancer : A Randomized Phase III Trial-FIRSTANA ', Journal of Clinical Oncology, vol. 35, no. 28, pp. 3189-3197 . https://doi.org/10.1200/JCO.2016.72.1068
Academic Journal
Li J; Centre for Personalised Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Brisbane, QLD, Australia.; Wuethrich A; Centre for Personalised Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Brisbane, QLD, Australia. a.wuethrich@uq.edu.au.; Sina AAI; Centre for Personalised Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Brisbane, QLD, Australia.; Cheng HH; Centre for Microscopy and Microanalysis, The University of Queensland, Brisbane, QLD, Australia.; Wang Y; Department of Molecular Sciences, ARC Centre of Excellence for Nanoscale BioPhotonics, Faculty of Science and Engineering, Macquarie University, Sydney, NSW, Australia. yuling.wang@mq.edu.au.; Behren A; Oliva Newton-John Cancer Research Institute, School of Cancer Medicine, La Trobe University, Heidelberg, VIC, Australia.; Department of Medicine, University of Melbourne, Heidelberg, VIC, Australia.; Mainwaring PN; Centre for Personalised Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Brisbane, QLD, Australia.; Trau M; Centre for Personalised Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Brisbane, QLD, Australia. m.trau@uq.edu.au.; School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD, Australia. m.trau@uq.edu.au.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Koo KM; Centre for Personalized Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, QLD, 4072, Australia.; Wee EJ; Centre for Personalized Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, QLD, 4072, Australia.; Mainwaring PN; Centre for Personalized Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, QLD, 4072, Australia.; Wang Y; Centre for Personalized Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, QLD, 4072, Australia.; Trau M; Centre for Personalized Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, QLD, 4072, Australia.; School of Chemistry and Molecular Biosciences, The University of Queensland, QLD, 4072, Australia.
Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 101235338 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1613-6829 (Electronic) Linking ISSN: 16136810 NLM ISO Abbreviation: Small Subsets: MEDLINE
Academic Journal
Smith MR; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA. Electronic address: MRSMITH@mgh.harvard.edu.; Saad F; Centre Hospitalier de l'Université de Montréal, Université de Montréal, Montréal, Québec, Canada.; Chowdhury S; Guy's, King's, and St. Thomas' Hospitals, and Sarah Cannon Research Institute, London, UK.; Oudard S; Georges Pompidou Hospital, University de Paris, Paris, France.; Hadaschik BA; University of Duisburg-Essen, Essen, and Ruprecht-Karls University Heidelberg, Heidelberg, Germany.; Graff JN; VA Portland Health Care System, Portland and Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.; Olmos D; Spanish National Cancer Research Centre (CNIO), Madrid and Biomedical Research Institute of Málaga (IBIMA), Spain.; Mainwaring PN; Canossa Hospital, Oxley, Queensland, Australia.; Lee JY; St. Mary's Hospital of Catholic University, Seoul, South Korea.; Uemura H; Yokohama City University Medical Center, Yokohama, Japan.; De Porre P; Janssen Research & Development, Beerse, Belgium.; Smith AA; Janssen Research & Development, Spring House, PA, USA.; Brookman-May SD; Janssen Research & Development, Los Angeles, CA, USA; Ludwig Maximilians University, Munich, Germany.; Li S; Janssen Research & Development, Spring House, PA, USA.; Zhang K; Janssen Research & Development, San Diego, CA, USA.; Rooney B; Janssen Research & Development, High Wycombe, UK.; Lopez-Gitlitz A; Janssen Research & Development, Los Angeles, CA, USA.; Small EJ; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.
Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: MEDLINE
Academic Journal
Ahmed M; Centre for Personalized Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), Corner College and Cooper Roads, The University of Queensland, Brisbane, QLD 4072, Australia.; Koo KM; Centre for Personalized Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), Corner College and Cooper Roads, The University of Queensland, Brisbane, QLD 4072, Australia.; Mainwaring PN; Centre for Personalized Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), Corner College and Cooper Roads, The University of Queensland, Brisbane, QLD 4072, Australia.; Carrascosa LG; Centre for Personalized Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), Corner College and Cooper Roads, The University of Queensland, Brisbane, QLD 4072, Australia. Electronic address: lgcarrascosa@uq.edu.au.; Trau M; Centre for Personalized Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), Corner College and Cooper Roads, The University of Queensland, Brisbane, QLD 4072, Australia; School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD 4072, Australia. Electronic address: m.trau@uq.edu.au.
Publisher: Elsevier Science Publishers Country of Publication: England NLM ID: 8310903 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-3096 (Electronic) Linking ISSN: 01677799 NLM ISO Abbreviation: Trends Biotechnol Subsets: MEDLINE
Academic Journal
Stebbing J; Division of Cancer, Department of Surgery and Cancer, Imperial College London, London, United Kingdom.; Mainwaring PN; Center for Personalised Nanomedicine, University of Queensland, Brisbane, Queensland, Australia.; Curigliano G; Division of Early Drug Development, European Institute of Oncology, IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Pegram M; Stanford Comprehensive Cancer Institute, Stanford University School of Medicine, Stanford, CA.; Latymer M; Pfizer, Sandwich, United Kingdom.; Bair AH; Pfizer, New York, NY.; Rugo HS; University of California, San Francisco, Comprehensive Cancer Center, San Francisco, CA.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Academic Journal
Koo KM; Centre for Personalized Nanomedicine, Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Australia.; Mainwaring PN; Centre for Personalized Nanomedicine, Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Australia. drpaulmainwaring@gmail.com.; Tomlins SA; Department of Pathology, Department of Urology, Michigan Centre for Translational Pathology, Comprehensive Cancer Centre, University of Michigan, Ann Arbor, MI, USA. tomlinss@med.umich.edu.; Trau M; Centre for Personalized Nanomedicine, Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Australia. m.trau@uq.edu.au.; School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Australia. m.trau@uq.edu.au.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101500082 Publication Model: Print Cited Medium: Internet ISSN: 1759-4820 (Electronic) Linking ISSN: 17594812 NLM ISO Abbreviation: Nat Rev Urol Subsets: MEDLINE
Academic Journal
Koo KM; Centre for Personalized Nanomedicine, Australian Institute for Bioengineering and Nanotechnology , University of Queensland , Brisbane , QLD 4072 , Australia.; Wang J; Centre for Personalized Nanomedicine, Australian Institute for Bioengineering and Nanotechnology , University of Queensland , Brisbane , QLD 4072 , Australia.; Richards RS; The University of Queensland, Centre for Clinical Research , Brisbane , QLD 4029 , Australia.; QIMR Berghofer Medical Research Institute , Brisbane , QLD 4006 , Australia.; Farrell A; The University of Queensland, Centre for Clinical Research , Brisbane , QLD 4029 , Australia.; Yaxley JW; The University of Queensland, Centre for Clinical Research , Brisbane , QLD 4029 , Australia.; Department of Urology , Royal Brisbane and Women's Hospital , Brisbane , QLD 4029 , Australia.; Samaratunga H; The University of Queensland, Centre for Clinical Research , Brisbane , QLD 4029 , Australia.; Aquesta Specialized Uropathology, Brisbane , QLD 4066 , Australia.; Princess Alexandra Hospital , Brisbane , QLD 4102 , Australia.; Teloken PE; Department of Urology , Royal Brisbane and Women's Hospital , Brisbane , QLD 4029 , Australia.; Princess Alexandra Hospital , Brisbane , QLD 4102 , Australia.; Roberts MJ; The University of Queensland, Centre for Clinical Research , Brisbane , QLD 4029 , Australia.; Department of Urology , Royal Brisbane and Women's Hospital , Brisbane , QLD 4029 , Australia.; Coughlin GD; Department of Urology , Royal Brisbane and Women's Hospital , Brisbane , QLD 4029 , Australia.; Lavin MF; The University of Queensland, Centre for Clinical Research , Brisbane , QLD 4029 , Australia.; Mainwaring PN; Centre for Personalized Nanomedicine, Australian Institute for Bioengineering and Nanotechnology , University of Queensland , Brisbane , QLD 4072 , Australia.; Wang Y; Department of Molecular Sciences, Faculty of Science and Engineering , Macquarie University , Sydney , NSW 2109 , Australia.; Gardiner RA; The University of Queensland, Centre for Clinical Research , Brisbane , QLD 4029 , Australia.; Department of Urology , Royal Brisbane and Women's Hospital , Brisbane , QLD 4029 , Australia.; Edith Cowan University , Perth , WA 6027 , Australia.; Griffith University , Brisbane , QLD 4111 , Australia.; Trau M; Centre for Personalized Nanomedicine, Australian Institute for Bioengineering and Nanotechnology , University of Queensland , Brisbane , QLD 4072 , Australia.; School of Chemistry and Molecular Biosciences , University of Queensland , Brisbane , QLD 4072 , Australia.
Publisher: American Chemical Society Country of Publication: United States NLM ID: 101313589 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1936-086X (Electronic) Linking ISSN: 19360851 NLM ISO Abbreviation: ACS Nano Subsets: MEDLINE
Academic Journal
Koo KM; Centre for Personalized Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, QLD 4072, Australia.; Wee EJ; Centre for Personalized Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, QLD 4072, Australia.; Mainwaring PN; Centre for Personalized Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, QLD 4072, Australia.; Trau M; Centre for Personalized Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, QLD 4072, Australia.; School of Chemistry and Molecular Biosciences, The University of Queensland, QLD 4072, Australia.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Mainwaring, Paul N
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어